Adam H. Schechter is the CEO of Labcorp Holdings, taking the helm on November 1, 2019. Before leading Labcorp, he gained valuable experience as the Executive Vice President and President of Global Human Health at Merck & Co. Adam is...

Adam H. Schechter is the CEO of Labcorp Holdings, taking the helm on November 1, 2019. Before leading Labcorp, he gained valuable experience as the Executive Vice President and President of Global Human Health at Merck & Co. Adam is not just an executive but also has been active on various boards, including the European Federation of Pharmaceutical Industries and Associations. He is involved with organizations like Water.org and the National Alliance for Hispanic Health. Under Adam's leadership, Labcorp has been seen making significant strides, especially during critical times as the healthcare landscape evolved. He received a sign-on grant that bolstered his stock holdings, aligning his interests with those of the company. In 2023, Adam's total compensation was about $2.2 million, which includes a base salary of $1.2 million and performance-based bonuses. Interestingly, his stock holdings have significantly increased over the years. In June 2023, his reported holdings were at an impressive $17.01 million, reflecting his stake in the company's future.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Labcorp Holdings CEOs

L

Adam H. Schechter

CEO of Labcorp Holdings

Sector of Economy

Healthcare

Born

July 30, 2024 - 0 years ago

CEO of Labcorp Holdings for

5 years 5 months (Nov 2019 - Present)

Previous Experience

Unknown

Rivals

Competitors/colleagues of Adam H. Schechter

M

Brian S. Tyler

CEO of McKesson

2023 Compensation

Stock

$53.90M

Salary

$1.49M

Bonus

$0.00

Other

$864.73K

Total Holdings

$51.90M

M

August J. Troendle

Founder and CEO of Medpace Holdings, Inc.

2023 Compensation

Stock

$0.00

Salary

$825.00K

Bonus

$814.42K

Other

$17.33K

Total Holdings

$1.76B

Q

James E. Davis

CEO of Quest Diagnostics

2023 Compensation

Stock

$0.00

Salary

$1.18M

Bonus

$1.36M

Other

$346.71K

Total Holdings

$21.72M

W

Eric M. Green

CEO of West Pharmaceutical Services

2023 Compensation

Stock

$0.00

Salary

$1.14M

Bonus

$1.67M

Other

$92.48K

Total Holdings

$39.37M

H

Stanley M. Bergman

CEO of Henry Schein

2023 Compensation

Stock

$0.00

Salary

$1.63M

Bonus

$643.65K

Other

$341.74K

Total Holdings

$59.69M

Holdings

See how much did Adam H. Schechter make over time.

Adam Schechter's stock holdings depict a noticeable growth pattern. In early 2023, his holdings were valued at approximately $17.01 million, continuing a climb from past values over the years. For example, in late 2021, they reached around $12.90 million, reflecting...

Adam Schechter's stock holdings depict a noticeable growth pattern. In early 2023, his holdings were valued at approximately $17.01 million, continuing a climb from past values over the years. For example, in late 2021, they reached around $12.90 million, reflecting the trust investors have in his leadership. His most significant holdings came during the peak period when he was awarded performance shares upon becoming CEO. The trend shows how his wealth is tied to the company's performance, ensuring his goals align with those of Labcorp's shareholders. This alignment fosters a sense of responsibility and dedication towards advancing Labcorp's mission in the healthcare sector.

Total Stock Sold

$61.21M

MRK

$61.21M

991,981 MRK shares

What if they kept their stock?

If Adam H. Schechter didn't sell their stock, today they would have:
Extra MRK991,981 shares worth $81.83M.
This is 33.69% and $20.62M more than what they got when they sold the stock.

Charitable Transactions

MRK

750 shares

MRK

Recent Charitable Transactions

MRK

750 shares

MRK

Dec 15, 2017

Charity

Insider Trading

See recent insider trades of Adam H. Schechter.

MRK

$20.51M

MRK at $73.82/share

Nov 1, 2018

Sale

MRK

$7.53M

MRK at $70.18/share

Sep 17, 2018

Sale

MRK

$8.18M

MRK at $61.00/share

Jun 18, 2018

Sale

MRK

$1.87M

MRK at $54.72/share

Feb 27, 2018

Received

MRK

$6.26M

MRK at $61.63/share

Jan 16, 2018

Sale

MRK

750 shares

MRK

Dec 15, 2017

Charity

Compensation History

See how much did Adam H. Schechter make over time.

In 2023, Adam Schechter's total compensation was around $2.2 million. This includes a base salary of $1.2 million, cash bonuses based on performance, and value from vested stock units. In the previous years, his compensation peaked at over $20 million in 2021, showcasing a strong performance during his initial years at Labcorp. The company ties his bonuses to specific executive performance metrics, focusing on achieving growth and operational efficiency. His compensation reflects a balance between fixed salary and performance incentives, pushing for a results-driven leadership approach that resonates in the changing healthcare environment. Labcorp's compensation philosophy aims to mesh well with long-term goals, ensuring that executives are rewarded as the company thrives.

Year

2023

Total Compensation

$2.40M

Salary

$1.20M

Board Justification

Labcorp's compensation philosophy is designed to align executive pay with company performance, focusing on long-term value creation and competitive benchmarking against peers.

Bonus

$300.00K

Board Justification

The bonus is based on the company's performance metrics, including revenue growth and operational efficiency, paid out in cash for the fiscal year 2023.

Other

$150.00K

Board Justification

Other compensation includes retirement contributions, life insurance premiums, and other benefits paid in 2023.

Restricted Stock

$750.00K(5K RSU)

Board Justification

5,000 shares of restricted stock units (RSUs) vested in 2023, reflecting the company's stock performance and retention strategy.

Performance Metrics

Performance metrics for 2023 included revenue growth, adjusted earnings per share, and operational efficiency targets.

Other Labcorp Holdings CEOs

Here are other CEOs of Labcorp Holdings

David P. King

Ex-CEO of Labcorp Holdings

January 2007 - October 2019